Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

New drug delivery methods can make natural compounds more effective and stable.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Both immature and mature fat cells are important for hair growth cycles, with immature cells promoting growth and mature cells possibly inhibiting it.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Behavior therapy and medications, especially clomipramine, can help reduce hair pulling in people with trichotillomania.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

MED1 affects skin wound healing differently in young and old mice.

COVID-19 may harm male fertility and damage the reproductive system.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Exosomes are important for skin health and could help diagnose and treat skin diseases.

Exosomes help nerve fibers grow by affecting specific cell signaling pathways.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

Adiponectin and bradykinin play important roles in skin health and may help treat skin conditions.

Skin cell-derived vesicles can help heal skin injuries effectively.

Astrotactin proteins are important for brain and skin development and are linked to several neurodevelopmental disorders.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.